These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 18837090

  • 1. Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors.
    Kwon JB, Park K, Kim YD, Seo JH, Moon SW, Cho DG, Kim YW, Kim DG, Yoon SK, Lim HW.
    World J Gastroenterol; 2008 Oct 07; 14(37):5717-22. PubMed ID: 18837090
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.
    Kow AW, Kwon CH, Song S, Kim JM, Joh JW.
    Surgery; 2015 Apr 07; 157(4):645-53. PubMed ID: 25794626
    [Abstract] [Full Text] [Related]

  • 3. Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma.
    Nakajima J, Tanaka M, Matsumoto J, Takeuchi E, Fukami T, Takamoto S.
    World J Surg; 2005 Jun 07; 29(6):715-8. PubMed ID: 16078127
    [Abstract] [Full Text] [Related]

  • 4. Clinical Factors Predictive of a Better Prognosis of Pulmonary Metastasectomy for Hepatocellular Carcinoma.
    Wang L, Ye G, Zhan C, Sun F, Lin Z, Jiang W, Wang Q.
    Ann Thorac Surg; 2019 Dec 07; 108(6):1685-1691. PubMed ID: 31445050
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Analysis of Surgical Resection for Pulmonary Metastasis from Hepatocellular Carcinoma.
    Takahashi Y, Ikeda N, Nakajima J, Sawabata N, Chida M, Horio H, Okumura S, Kawamura M, Metastatic Lung Tumor Study Group of Japan.
    World J Surg; 2016 Sep 07; 40(9):2178-85. PubMed ID: 27255943
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary metastasectomy for hepatocellular carcinoma.
    Chen YJ, Hsu HS, Hsieh CC, Wu YC, Wang LS, Hsu WH, Huang MH, Huang BS.
    J Chin Med Assoc; 2004 Dec 07; 67(12):621-4. PubMed ID: 15779485
    [Abstract] [Full Text] [Related]

  • 7. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E, Allard MA, Selten J, Golse N, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Adam R.
    Liver Transpl; 2017 Apr 07; 23(4):440-447. PubMed ID: 28187493
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic significance and indications of pulmonary metastasectomy for hepatocellular carcinoma following liver resection.
    Hu Z, Li W, Huang P, Zhou Z, Xu J, Xu K, Wang J, Zhang H.
    Int J Surg; 2017 Dec 07; 48():23-31. PubMed ID: 28987561
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary metastasectomy for metastasized hepatocellular carcinoma after liver resection and liver transplantation: a single center experience.
    Hau HM, Schmelzle M, Benzing C, Ascherl R, Tautenhahn HM, Gäbelein G, Eichfeld U, Bartels M.
    Z Gastroenterol; 2016 Jan 07; 54(1):31-9. PubMed ID: 26619391
    [Abstract] [Full Text] [Related]

  • 10. Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma.
    Kitano K, Murayama T, Sakamoto M, Nagayama K, Ueno K, Murakawa T, Nakajima J.
    Eur J Cardiothorac Surg; 2012 Feb 07; 41(2):376-82. PubMed ID: 21727012
    [Abstract] [Full Text] [Related]

  • 11. Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma.
    Nakamura A, Esaki M, Nakagawa K, Asakura K, Kishi Y, Nara S, Shimada K, Watanabe SI.
    Gen Thorac Cardiovasc Surg; 2019 Sep 07; 67(9):782-787. PubMed ID: 30820914
    [Abstract] [Full Text] [Related]

  • 12. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.
    World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007
    [Abstract] [Full Text] [Related]

  • 13. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
    Castroagudín JF, Molina-Pérez E, Ferreiro-Iglesias R, Abdulkader I, Otero-Antón E, Tomé S, Varo-Pérez E.
    Transplant Proc; 2012 Apr 28; 44(6):1565-7. PubMed ID: 22841215
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan.
    Hiraki T, Yamakado K, Ikeda O, Matsuoka T, Kaminou T, Yamagami T, Gobara H, Mimura H, Kawanaka K, Takeda K, Yamashita Y, Inoue Y, Ogawa T, Nishimura T, Kanazawa S.
    J Vasc Interv Radiol; 2011 Jun 28; 22(6):741-8. PubMed ID: 21531575
    [Abstract] [Full Text] [Related]

  • 15. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL, Ji WB, Zhao R, Duan WD, Chen YW, Wang XQ, Yu Q, Luo Y, Dong JH.
    World J Gastroenterol; 2015 Mar 28; 21(12):3599-606. PubMed ID: 25834326
    [Abstract] [Full Text] [Related]

  • 16. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S.
    Transplant Proc; 2012 Mar 28; 44(6):1713-6. PubMed ID: 22841251
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N, Tanriover B, Singal AG, Marrero JA.
    Transplantation; 2017 Jan 28; 101(1):e12-e19. PubMed ID: 28009759
    [Abstract] [Full Text] [Related]

  • 18. Clinical Significance of Multiple Pulmonary Metastasectomy for Hepatocellular Carcinoma.
    Mizuguchi S, Nishiyama N, Izumi N, Tsukioka T, Komatsu H, Iwata T, Tanaka S, Takemura S, Kubo S.
    World J Surg; 2016 Feb 28; 40(2):380-7. PubMed ID: 26306890
    [Abstract] [Full Text] [Related]

  • 19. Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
    Ohba T, Yano T, Yoshida T, Kawano D, Tsukamoto S, Shoji F, Taketomi A, Saitsu H, Takeo S, Maehara Y.
    Surg Today; 2012 Jun 28; 42(6):526-31. PubMed ID: 22173647
    [Abstract] [Full Text] [Related]

  • 20. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q, Shang L, Zang Y, Chen X, Zhang L, Wang Y, Wang L, Liu Y, Mao S, Shen Z.
    Eur J Gastroenterol Hepatol; 2014 May 28; 26(5):544-52. PubMed ID: 24614696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.